Security Snapshot

Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 per share (KTTA) Institutional Ownership

CUSIP: 70261F202

13F Institutional Holders and Ownership History from Q1 2024 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

24

Shares (Excl. Options)

16.79MFull value: 16,787,049 · shares · 30 Jun 2026

Price

$0.52

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, par value $0.0001 per share
Symbol
KTTA on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
16,787,049
Latest holder snapshot 5 signals
Total 13F value
$8,661,880
Portfolio coverage rank
0%
Share change
+3,968,281
Value change
+$2,045,156
Number of holders
24
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
92,960,340
SEC-reported price per share
$0.45
Insider filing price
$0.45
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • KTTA - Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 per share is tracked under CUSIP 70261F202.
  • 24 institutions reported positions in Q2 2026.
  • 14 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 21 to 24 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $9.52MFull value: $9,515,703 · USD · 31 Mar 2026
    to
    $8.66MFull value: $8,661,880 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 24 institutions filings for Q2 2026.

Open SEC evidence

Security key

70261F202

13F reference period

Q2 2026

13F holders

24

13D/G owners

14

CIK / CUSIP context first

Open Q2 2026 holders KTTA full holder history Pasithea Therapeutics Corp. SEC filings Pasithea Therapeutics Corp. company facts Pasithea Therapeutics Corp. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
14
Security
KTTA
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 10% $7,160,756 10,229,652 JANUS HENDERSON GROUP PLC 28 Nov 2025
Vivo Opportunity Fund Holdings, L.P. 10% 0% $4,550,502 -$4,054,127 9,286,738 -47% Vivo Opportunity Fund Holdings, L.P. 30 Jun 2026
Coastlands Capital LP 11% +15% $2,339,371 +$878,565 3,835,035 +60% Coastlands Capital LP 09 Apr 2026
Adage Capital Management, L.P. 10% $2,050,179 2,329,749 Adage Capital Management, L.P. 31 Dec 2025
Squadron Capital Management LLC 9.9% 0% $2,050,179 +$67,601 2,329,749 +3.4% Squadron Master Fund LP 31 Dec 2025
Opaleye Management Inc. 6.1% -38% $1,004,500 -$216,090 2,050,000 -18% Opaleye Management Inc. 30 Jun 2026
Stonepine Capital Management, LLC 5.8% $1,366,785 1,952,550 Stonepine Capital Management, LLC 17 Jun 2026
Funicular Funds, LP 7.4% $1,416,424 1,839,512 Funicular Funds, LP 15 Apr 2026
AMERIPRISE FINANCIAL INC 5.4% -38% $1,026,681 -$440,216 1,350,896 -30% Ameriprise Financial, Inc. 31 Mar 2026
CVI Investments, Inc. 3.8% -61% $791,995 +$64,987 899,994 +8.9% CVI Investments, Inc. 31 Dec 2025
Orca Capital AG 4.9% -13% $613,228 -$14,002 362,857 -2.2% Orca Capital AG 07 May 2025
INTRACOASTAL CAPITAL, LLC 5% $537,188 317,863 Mitchell P. Kopin 06 May 2025
ARMISTICE CAPITAL, LLC 5% -50% $240,119 +$14,019 142,082 +6.2% Armistice Capital, LLC 31 Mar 2025
STEINMAN LAWRENCE 3.1% $141,720 83,858 Lawrence Steinman 01 Mar 2025
As of 30 Jun 2026, 24 institutional investors reported holding
16.79MFull value: 16,787,049 · shares · 30 Jun 2026
shares of Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 per share (KTTA). This represents 18% of the company’s total
92.96MFull value: 92,960,340 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 24 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
18%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Cable Car Capital, LP 3.2% 3,000,000 +149% 0.03% $1,546,200
Stonepine Capital Management, LLC 2.4% 2,201,468 +165% 0.87% $1,134,637
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.3% 2,100,000 0% 0% $1,082,340
Jupiter Topco LLC 2.3% 2,100,000 0% 0% $1,092,315
Opaleye Management Inc. 2.2% 2,050,000 0.1% $1,056,570
AMERIPRISE FINANCIAL INC 2% 1,864,485 +38% 0% $960,955
Squadron Capital Management LLC 1.1% 1,000,000 -52% 0.18% $515,400
AdvisorShares Investments LLC 1% 937,550 +178% 0.06% $483,213
Vivo Capital, LLC 0.5% 465,471 -78% 0.02% $239,904
Persistent Asset Partners Ltd 0.31% 290,555 0% 0.05% $149,752
UBS Group AG 0.2% 188,111 +619% 0% $96,877
XTX Topco Ltd 0.14% 127,572 +278% 0% $65,751
VANGUARD CAPITAL MANAGEMENT LLC 0.14% 126,279 +135% 0% $65,034
GEODE CAPITAL MANAGEMENT, LLC 0.09% 83,856 -19% 0% $43,221
RENAISSANCE TECHNOLOGIES LLC 0.07% 65,600 -30% 0% $33,810
TWO SIGMA INVESTMENTS, LP 0.07% 64,166 +205% 0% $33,071
VANGUARD FIDUCIARY TRUST CO 0.05% 43,860 0% 0% $22,588
NORTHERN TRUST CORP 0.03% 31,405 +62% 0% $16,186
Jump Financial, LLC 0.03% 29,363 0% $15,133
Tower Research Capital LLC (TRC) 0.01% 8,838 +377% 0% $4,555
Hurley Capital, LLC 0.01% 7,000 +90% 0% $3,608
SBI Securities Co., Ltd. 0% 1,051 0% 0% $542
BARCLAYS PLC 0% 269 0% $139
JPMORGAN CHASE & CO 0% 150 0% 0% $79

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
11
Headline period
Q2 2026
Rows shown
1-11 of 11
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 1,051 $518 $0.49 1
2026 Q2 16,787,049 $8,661,880 +$2,045,156 $0.52 24
2026 Q1 12,818,768 $9,515,703 -$559,110 $0.74 21
2025 Q4 12,892,082 $16,641,289 +$13,193,231 $1.29 24
2025 Q3 612,004 $441,403 +$224,539 $0.73 18
2025 Q2 300,344 $216,624 +$151,923 $0.72 10
2025 Q1 78,704 $99,102 -$116,583 $1.30 7
2024 Q4 77,162 $243,273 +$214,440 $3.15 7
2024 Q3 9,086 $48,891 -$103,371 $5.42 6
2024 Q2 29,996 $151,569 -$300 $5.06 7
2024 Q1 30,055 $218,102 +$218,102 $7.28 6
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .